BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $... (ying itsexpertise in nanochips nanodevic...)

BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome

Date:9/27/2007

ying its expertise in nanochips, nanodevices and nanosystems to develop its patented platform technology to provide fast, comprehensive, and low-cost analysis of genomic, epigenomic and proteomic information with sensitivity at the single cell/single molecule level. BioNanomatrix' technologies are licensed exclusively from Princeton University. Founded as a spin-out of Princeton University in 2003, the company is headquartered in Philadelphia, Pennsylvania. For more information, visit: http://www.BioNanomatrix.com.

About Complete Genomics

Complete Genomics Inc. (CGI) is a high-performance DNA sequencing company whose mission is to dramatically reduce the cost of DNA sequencing for research, drug development, and diagnostic applications. Founded in 2005, the company has developed a novel combination of high-density DNA nanoarrays, sequencing-by-hybridization and combinatorial probe-ligation chemistry, and high-performance computing techniques that promise to provide researchers and clinicians with fast, accurate, and inexpensive complete human genome sequencing. For more information, visit: http://www.completegenomics.com.

Contact:

Barbara Lindheim

GendeLLindheim BioCom Partners

212 918-4650

SOURCE BioNanomatrix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3
Related biology technology :

1. National Instruments DIAdem -- Complete Your Technical Data Management Framework with Powerful Off-line Analysis, Visualization, and Report Generation
2. Potawatomis complete acquisition of tech firm
3. Sonic Foundry completes $11.25M stock offer
4. Orion Energy completes $5M capital round
5. RedPrairie completes MARC acquisition
6. Metavante completes purchase of check processing firm
7. GE completes $1.2 billion acquisition
8. M & Is Metavante completes Brasfield Corp. acquisition
9. Berbee Data Centers complete audit, certification
10. Metavante completes GHR Systems acquisition
11. Metavante completes TREEV acquisition

Post Your Comments:

(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-As...mes; markets are in turmoil and uncertainty is par...that the pharma industry has been,relatively immun...t take a,vacation. , During the midst of ...giant Johnson & Johnson inaugurated an R&D...

(Date:12/1/2009)..., , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswi...: PDLI ) today announced revenue guidance for the...mately $57 million, as compared with $69 million f...quarter 2008 results was the first of two installm...included in fourth quarter 2008 results was a one-...

(Date:12/1/2009)..., , PLYMOUTH, Mass., Dec. 1 /PRNewswire/ -... ) announced today results from the company sponso...achandra Medical Center in Chennai, India using th...-reconstructable Critical Limb Ischemia (CLI). Sri...nternational-associated institution based in Chenn...

(Date:12/1/2009)..., , SARASOTA, Fla., Dec. 1 /PRNewswire/ ...ucts, Osprey Biotechnics Inc. of Sarasota has appo...distributor. ,, Lake is located near Birmingha...ficial bacteria which serve the agricultural, wast...re bred to be hungry and to open drain fields, and...

Breaking Biology Technology:Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2 Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3 PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2 PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3 Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2 Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3

[0] Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit [0] PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million [0] Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia [0] Osprey Expands In Europe

... Celator Pharmaceuticals today,announced that Scot...o,present at the BIO Investor Forum in San Francis...and an update on the company,s clinical,developmen...sday, October,29, 2008 at 1:45 PM PDT in the Marin...pleased to announce that Dr. Arthur Louie, chief,m...

...Alfacell Corporation,(Nasdaq: ACEL ) today announ...scal year ended July 31, 2008, filed with the Secu...ncluded an audit opinion from its independent,regi... about the company,s,ability to continue as a goin...compliance with NASDAQ Marketplace Rule 4350(b)(1)...

...pril 27, 2009 to Regain Compliance with $1.00 ...IN, Calif., Oct. 23 Peregrine,Pharmaceuticals, In...tical,company developing monoclonal antibodies for...ons, today announced that it has received a letter...al time to regain,compliance with the minimum bid ...

Other Biology Technology:Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum 2 Alfacell Receives Going Concern Audit Opinion 2 Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2

Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum Alfacell Receives Going Concern Audit Opinion Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule

(Date:12/2/2009)...University Medical Center researchers have figured...glioma may be better able to resist radiation ther...ing pathway in these cancer stem cells, they were ... in a laboratory experiment. , The work builds ... cells resist the effects of radiation much better...

(Date:12/2/2009)...e smokeless tobacco product called moist snuff pl...nnesota to urge the tobacco industry to change man...carcinogens. Their study is published online in AC...y . It reports that this category of tobacco produ...oxic and cancer-causing substances. Called polycyc...

(Date:12/2/2009)...r muscles can twitch, before the thought telling i...te of sortscalled an ion channelmust open in the s...chemical signals that spur the cell to action. New...and Technology (NIST) has allowed scientists to ob... the first time, potentially offering insights for...

[0] Discovery makes brain tumor cells more responsive to radiation [0] Smokeless tobacco called 'moist snuff' is contaminated with harmful substances [0] Nervy research: Researchers take initial look at ion channels in a model system

...pidly distributing antibiotics to people,exposed t...ld by,itself, prevent about 70 percent of anthrax ...s from the Johns Hopkins Bloomberg School of,Publi...rcent, their,study found that at least 63 percent ...vaccine before an anthrax attack, which might not ...

... Southwestern Medical Center at Dallas,researchers...s of mice,to fight against amyloid proteins that c...ic of Alzheimer,s disease.,For years scientists ha...ed vaccine to slow the progression of the disease ...ave created a gene-based,vaccine aimed at stimulat...

...ientists have believed that neurons need a long pe...s before they take on their adult role. But after ...hese cells develop, a team of researchers at the S...eurons come into this world with a good idea about...is detailed in a paper in the March 24 issue of Ne...

Other Biology News:Study Models Impact Of Anthrax Vaccine 2 Scientists identify molecular events that drive cell senescence 2 First real-time view of developing neurons reveals surprises, say Stanford researchers 2

Study Models Impact Of Anthrax Vaccine Scientists identify molecular events that drive cell senescence First real-time view of developing neurons reveals surprises, say Stanford researchers

Rabbit Anti-FOXJ2 Polyclonal Antibody, Unconjugated from Abcam

Mouse Anti-Selenoprotein P Monoclonal Antibody, Unconjugated, Clone 35 from BD Biosciences Pharmingen

Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam

Anti-Phosphotyrosine IgG Monoclonal Antibody, Alkaline Phosphatase Conjugated, Clone AD548 from Assay Designs/Stressgen Bioreagents

Biology Products:

Rabbit Anti-FOXJ2 Polyclonal Antibody, Unconjugated from Abcam Mouse Anti-Selenoprotein P Monoclonal Antibody, Unconjugated, Clone 35 from BD Biosciences Pharmingen Mouse Anti-HSV1, HSV2 ICP5 Major Capsid Protein Monoclonal Antibody, Unconjugated, Clone 3B6 from Abcam Anti-Phosphotyrosine IgG Monoclonal Antibody, Alkaline Phosphatase Conjugated, Clone AD548 from Assay Designs/Stressgen Bioreagents

BioNanoatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $...(ying itsexpertise in nanochips nanodevic...)